Login / Signup

CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011-2018.

Emily E RicottaD Rebecca PrevotsKenneth N Olivier
Published in: ERJ open research (2022)
CFTR modulator therapy is associated with a decreased risk of NTM positivity in individuals with cystic fibrosis.
Keyphrases
  • cystic fibrosis
  • pseudomonas aeruginosa
  • lung function
  • stem cells
  • chronic obstructive pulmonary disease
  • mesenchymal stem cells
  • cell therapy
  • smoking cessation